Skip to main content
SpringerLink
Log in

The Role of Magnesium in the Cardiovascular System

  • Chapter
  • First Online:
Magnesium in Human Health and Disease

Part of the book series: Nutrition and Health ((NH))

  • 2292 Accesses

Abstract

Prior epidemiological trials from several countries, such as the USA, South Africa, Finland, France, England, Canada, Germany, and the Netherlands [1–17], have demonstrated that water magnesium content is associated with incidence and mortality from coronary artery disease (CAD). Autopsies have demonstrated high concentrations of cardiac muscle magnesium (also called “hard water areas”) compared to low magnesium water areas (also called “soft water areas”) and vice versa [1, 12, 15–17].

The authors state that no conflict of interest exists regarding the possible publication of this article.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Seelig MS, Rosanoff A. In: Seelig MS, Rosanoff A, editors. The magnesium factor. New York: Avery Publishers; 2003.

    Google Scholar 

  2. Wacker WEC, Parisi AF. Magnesium metabolism. N Engl J Med. 1968;278:658–63.

    Article  PubMed  CAS  Google Scholar 

  3. Shechter M, Kaplinsky E, Rabinowitz B. The rationale of magnesium supplementation in acute myocardial infarction. A review of the literature. Arch Intern Med. 1992;152:2189–96.

    Article  PubMed  CAS  Google Scholar 

  4. Whang R, Flink E, Dyckner T, et al. Magnesium depletion as a cause of refractory potassium repletion. Arch Intern Med. 1985;145:1686–9.

    Article  PubMed  CAS  Google Scholar 

  5. Ryzen E, Elkayam U, Rude RK. Low blood mononuclear cell magnesium content in intensive cardiac care unit patients. Am Heart J. 1986;111:475–80.

    Article  PubMed  CAS  Google Scholar 

  6. Reinhart RA. Magnesium metabolism. Arch Intern Med. 1988;148:2415–20.

    Article  PubMed  CAS  Google Scholar 

  7. Elin RJ. Status of the determination of magnesium in mononuclear blood cells in humans. Magnesium. 1988;7:300–5.

    PubMed  CAS  Google Scholar 

  8. Haigney MCP, Silver B, Tanglao E, et al. Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation. 1995;92:2190–7.

    Article  PubMed  CAS  Google Scholar 

  9. Cohen L. Physiologic assessment of magnesium status in humans: a combination of load retention and renal excretion. IMAJ. 2000;2:938–9.

    PubMed  CAS  Google Scholar 

  10. Seelig MS. The requirement of magnesium by the normal adult. Am J Clin Nutr. 1964;6:342–90.

    Google Scholar 

  11. Centers for Disease Control and Prevention. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase I, 1988–91, Advance data from vital and health statistics, vol. 258. Hyattsville: National Center for Health Statistics; 1994. p. 1–28.

    Google Scholar 

  12. Lowenstein FW, Stanton MF. Serum magnesium levels in the United States, 1971–1974. J Am Coll Nutr. 1986;5(4):399–414.

    PubMed  CAS  Google Scholar 

  13. Seelig MS. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations- magnesium and chloride loss in refractory potassium repletion. Am J Cardiol. 1989;63:4G–21.

    Article  PubMed  CAS  Google Scholar 

  14. Lichton IJ. Dietary intake levels of requirements of Mg and Ca for different segments of the U.S. population. Magnesium. 1989;8:117–23.

    PubMed  CAS  Google Scholar 

  15. Peterson DR, Thompson DJ, Nam JM. Water hardness, arteriosclerotic heart disease and sudden death. Am J Epidemiol. 1970;92:90–3.

    PubMed  CAS  Google Scholar 

  16. Shaper AG. Soft water, heart attacks, and stroke. J Am Med Assoc. 1974;230:130–1.

    Article  CAS  Google Scholar 

  17. Anderson TW, Neri LC, Schreiber GB, et al. Ischemic heart disease, water hardness and myocardial magnesium. CMA J. 1975;113:199–203.

    CAS  Google Scholar 

  18. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1998;136:480–90.

    Article  PubMed  CAS  Google Scholar 

  19. Ford ES. Serum magnesium and ischemic heart disease: findings from national sample of US adults. Int J Epidemiol. 1999;28:645–51.

    Article  PubMed  CAS  Google Scholar 

  20. Abbott RD, Ando F, Masaki KH, et al. Dietary magnesium intake and the future risk of coronary heart disease (The Honolulu Heart Program). Am J Cardiol. 2003;92:665–9.

    Article  PubMed  CAS  Google Scholar 

  21. Amighi J, Sabeti S, Schlager O, et al. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke. 2004;35:22–7.

    Article  PubMed  CAS  Google Scholar 

  22. He K, Liu K, Daviglus ML, Morris SJ, et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113:1675–82.

    Article  PubMed  CAS  Google Scholar 

  23. Anderson TW, Le Riche WH, MacKay JS. Sudden death and ischemic heart disease. Correlation with hardness of local water supply. N Engl J Med. 1969;280:805–7.

    Article  PubMed  CAS  Google Scholar 

  24. Johnson CJ, Peterson DR, Smith EK. Myocardial tissue concentrations of magnesium and potassium in men dying suddenly from ischemic heart disease. Am J Clin Nutr. 1979;32:967–70.

    PubMed  CAS  Google Scholar 

  25. Peacock JM, Ohira T, Post W, et al. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2010;160:464–70.

    Article  PubMed  CAS  Google Scholar 

  26. Chiuve SE, Korngold EC, Januzzi Jr JL, et al. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. 2011;93:253–60.

    Article  PubMed  CAS  Google Scholar 

  27. Pachikian BD, Neyrinck AM, Deldicque L, et al. Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J Nutr. 2010;140:509–14.

    Article  PubMed  CAS  Google Scholar 

  28. Lin CY, Tsai PS, Hung YC, et al. L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate. Br J Anaesth. 2010;104:44–51.

    Article  PubMed  CAS  Google Scholar 

  29. King DE. Inflammation and elevation of C-reactive protein: does magnesium play a key role? Magnes Res. 2009;22:57–9.

    PubMed  CAS  Google Scholar 

  30. Song Y, Li TY, van Dam RM, et al. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr. 2007;85:1068–74.

    PubMed  CAS  Google Scholar 

  31. Chacko SA, Song Y, Nathan L, et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care. 2010;33:304–10.

    Article  PubMed  CAS  Google Scholar 

  32. Shechter M, Kaplinsky E, Rabinowitz B. Review of clinical evidence – is there a role for supplemental magnesium in acute myocardial infarction in high-risk populations (patients ineligible for thrombolysis and the elderly)? Coron Artery Dis. 1996;7:352–8.

    Article  PubMed  CAS  Google Scholar 

  33. Shechter M. Does magnesium have a role in the treatment of patients with coronary artery disease? Am J Cardiovasc Drugs. 2003;3:231–9.

    Article  PubMed  CAS  Google Scholar 

  34. Shechter M, Shechter A. Magnesium and myocardial infarction. Clin Calcium. 2005;11:111–5.

    Google Scholar 

  35. Iseri LT, French JH. Magnesium: nature’s physiologic calcium blocker. Am Heart J. 1984;108:188–93.

    Article  PubMed  CAS  Google Scholar 

  36. Holroyde MJ, Robertson SP, Johnson JD, et al. The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J Biol Chem. 1980;255:11688–91.

    PubMed  CAS  Google Scholar 

  37. Sordahl LA. Effects of magnesium on initial rates of calcium uptake and release of heart mitochondria. Arch Biochem Biophys. 1975;167:104–7.

    Article  PubMed  CAS  Google Scholar 

  38. Mroczek WJ, Lee WR, Davidov ME. Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology. 1977;28:720–4.

    Article  PubMed  CAS  Google Scholar 

  39. Cotton DB, Gonik B, Dorman KF. Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate. Am J Obstet Gynecol. 1984;148:162–5.

    PubMed  CAS  Google Scholar 

  40. Rasmussen HS, Larsen OG, Meier K, et al. Hemodynamic effects of intravenous administered magnesium in patients with ischemic heart disease. Int J Cardiol. 1988;11:824–8.

    CAS  Google Scholar 

  41. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. Magnesium. 1985;4:245–71.

    PubMed  CAS  Google Scholar 

  42. Altura BM. Magnesium neurohypophyseal hormone interactions in contraction of vascular smooth muscle. Am J Physiol. 1975;228:1615–20.

    PubMed  CAS  Google Scholar 

  43. Altura BM, Altura BT, Corella A. Magnesium deficiency-induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation. Science. 1983;221:376–8.

    Article  PubMed  CAS  Google Scholar 

  44. Altura BM, Altura BT. Vascular smooth muscle and prostaglandins. Fed Proc. 1976;35:2360–6.

    PubMed  CAS  Google Scholar 

  45. Askar AD, Mustafa SJ. Role of magnesium in the relaxation of coronary arteries by adenosine. Magnesium. 1983;2:17–25.

    CAS  Google Scholar 

  46. Whelton PK, Klay MJ. Magnesium and blood pressure: review of the epidemiologic and clinical trial experience. Am J Cardiol. 1989;63:26G–30.

    Article  PubMed  CAS  Google Scholar 

  47. Mizushima S, Cappuccio FP, Nichols R, et al. Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. J Hum Hypertens. 1998;12(7):447–53.

    Article  PubMed  CAS  Google Scholar 

  48. Kugiyama K, Yasue H, Okumara K, et al. Suppression of exercise-induced angina by magnesium sulfate in patients with variant angina. J Am Coll Cardiol. 1988;12:1177–83.

    Article  PubMed  CAS  Google Scholar 

  49. Jee HS, Miller 3rd ER, Guallar E, et al. The effect of magnesium supplementation on blood pressure. A meta analysis of clinical randomized trials. Am J Hypertens. 2002;15:691–6.

    Article  PubMed  CAS  Google Scholar 

  50. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:201–5.

    Article  PubMed  CAS  Google Scholar 

  51. Shechter M, Paul-Labrador M, Rude RK, et al. Intracellular magnesium predicts functional capacity in patients with coronary artery disease. Cardiology. 1998;90:168–72.

    Article  PubMed  CAS  Google Scholar 

  52. Shechter M, Bairey Merz CN, Stuehlinger HG, et al. Oral magnesium supplementation improves exercise duration and quality of life in patients with coronary artery disease. Am J Cardiol. 2003;91:517–21.

    Article  PubMed  CAS  Google Scholar 

  53. Pokan R, Hofmann P, von Duvillard SP, et al. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients. Br J Sports Med. 2006;40:773–8.

    Article  PubMed  CAS  Google Scholar 

  54. Greville GD, Lehmann H. Cation antagonism in blood coagulation. J Physiol. 1943;103:175–84.

    Google Scholar 

  55. Schnitzler B. Thromboseprophylaxe mit Magnesium. Munch med Wschr. 1957;99:81–4.

    PubMed  CAS  Google Scholar 

  56. Anstall HB, Huntsman RG, Lehmann H, et al. The effect of magnesium on blood coagulation in human subjects. Lancet. 1959;1:814–5.

    Article  PubMed  CAS  Google Scholar 

  57. Adams JH, Mitchel JRA. The effect of agents which modify platelet behavior and of magnesium ions on thrombus formation in vivo. Thromb Haemost. 1979;42:603–10.

    PubMed  CAS  Google Scholar 

  58. Frandsen NJ, Winther K, Pedersen F, et al. Magnesium and platelet function: in vivo influence on aggregation and alpha-granule release in healthy volunteers. Magnesium Bull. 1995;17:37–40.

    CAS  Google Scholar 

  59. Hwang DL, Yen CF, Nadler JL. Effect of extracellular magnesium on platelet activation and intracellular calcium mobilization. Am J Hypertens. 1992;5:700–6.

    PubMed  CAS  Google Scholar 

  60. Born GVR, Cross GP. Effect of inorganic ions and plasma proteins on the aggregation of blood platelets by adenosine diphosphate. J Physiol. 1964;170:397–414.

    PubMed  CAS  Google Scholar 

  61. Gawaz M, Ott I, Reininger AJ, et al. Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost. 1994;72:912–8.

    PubMed  CAS  Google Scholar 

  62. Nadler JL, Goodson S, Rude RK. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension. 1987;9:379–83.

    Article  PubMed  CAS  Google Scholar 

  63. Gawaz M. Effects of intravenous magnesium on platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Thromb Res. 1996;83:341–9.

    Article  PubMed  CAS  Google Scholar 

  64. Badimon L, Badimon JJ, Galvez A, et al. Influence of arterial damage and wall shear rate on platelet formation: ex vivo study in a swine model. Arteriosclerosis. 1986;6:312–20.

    Article  PubMed  CAS  Google Scholar 

  65. Shechter M, Bairey Merz CN, Rude RK, et al. Low intracellular magnesium levels promote platelet-dependent thrombus formation in patients with coronary artery disease. Am Heart J. 2000;140:212–8.

    Article  PubMed  CAS  Google Scholar 

  66. Shechter M, Bairey Merz CN, Paul-Labrador M, et al. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol. 1999;84:152–6.

    Article  PubMed  CAS  Google Scholar 

  67. Rukshin V, Azarbal B, Shah PK, et al. Intravenous magnesium in experimental stent thrombosis in swine. Arterioscler Thromb Vasc Biol. 2001;21:1544–9.

    Article  PubMed  CAS  Google Scholar 

  68. Rukshin V, Shah PK, Cercek B, et al. Comparative antithrombotic effects of magnesium sulfate and platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis. Circulation. 2002;105:1970–5.

    Article  PubMed  CAS  Google Scholar 

  69. Rukshin V, Santos R, Gheorghiu M, et al. A prospective, nonrandomized, open-labeled pilot study investigating the use of magnesium in patients undergoing nonacute percutaneous coronary intervention with stent implantation. J Cardiovasc Pharmacol Ther. 2003;8:193–200.

    Article  PubMed  CAS  Google Scholar 

  70. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. A marker of atherosclerotic risk. Arteriosc Thromb Vasc Biol. 2003;23:168–75.

    Article  CAS  Google Scholar 

  71. Corretti MC, Anderson TJ, Benjamin EJ, International Brachial Artery Reactivity Task Force, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. J Am Coll Cardiol. 2002;39:257–65.

    Article  PubMed  Google Scholar 

  72. Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cradiol. 1997;20:426–32.

    Article  CAS  Google Scholar 

  73. McLenachan JM, Williams JK, Fish RD, et al. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation. 1991;84:1272–7.

    Article  Google Scholar 

  74. Rizzoni D. Endothelial function in hypertension: fact or fantasy? J Hypertens. 2002;20:1479–81.

    Article  PubMed  CAS  Google Scholar 

  75. Drexler H, Hayoz D, Münzel T, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992;69:1596–601.

    Article  PubMed  CAS  Google Scholar 

  76. Widlansky ME, Gokce N, Keaney Jr JF, et al. The clinical implication of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149–60.

    Article  PubMed  CAS  Google Scholar 

  77. Lerman A, Zeiher AM. Endothelial function cardiac events. Circulation. 2005;111:363–8.

    Article  PubMed  Google Scholar 

  78. Shechter M, Sherer Y. Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk? Isr Med Assoc J. 2003;5:736–8.

    PubMed  Google Scholar 

  79. Shechter M, Sharir M, Labrador MJ, et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000;102:2353–8.

    Article  PubMed  CAS  Google Scholar 

  80. Pearson PJ, Evora PR, Seccombe JF, et al. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations. Ann Thor Surg. 1998;65:967–72.

    Article  CAS  Google Scholar 

  81. Paravicini TM, Yogi A, Mazur A, et al. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension. 2009;53:423–9.

    Article  PubMed  CAS  Google Scholar 

  82. Vormann J, Fiscer G, Classen HG, et al. Influence of decreased and increased magnesium supply on cardiotoxic effects of epinephrine in rats. Arzneimittelforschung. 1983;33:205–10.

    PubMed  CAS  Google Scholar 

  83. Banai S, Haggroth L, Epstein SE, et al. Influence of extracellular magnesium on capillary endothelial cell proliferation and migration. Circ Res. 1990;67:645–50.

    Article  PubMed  CAS  Google Scholar 

  84. Weisman HF, Bush DE, Mannisi JA, et al. Cellular mechanisms of myocardial infarct expansion. Circulation. 1988;78:186–201.

    Article  PubMed  CAS  Google Scholar 

  85. Dickens BF, Weglicki WB, Li YS, et al. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS. 1992;311:187–91.

    Article  CAS  Google Scholar 

  86. Rasmussen HS, Aurup P, Goldstein K, et al. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. Arch Intern Med. 1989;149:1050–3.

    Article  PubMed  CAS  Google Scholar 

  87. Davis WH, Leary WP, Reyes AH. Monotherapy with magnesium increases abnormally low high density lipoprotein cholesterol: a clinical assay. Curr Ther Res. 1984;36:341–4.

    Google Scholar 

  88. Niemela JE, Csako G, Bui MN, et al. Gender-specific correlation of platelet ionized magnesium and serum low-density cholesterol concentrations in apparently healthy subjects. J Lab Clin Med. 1997;129:89–96.

    Article  PubMed  CAS  Google Scholar 

  89. Ouchi Y, Tabata RE, Stergiopoulos K, et al. Effect of dietary magnesium on development of atherosclerosis in cholesterol fed rabbits. Arteriosclerosis. 1990;10:732–7.

    Article  PubMed  CAS  Google Scholar 

  90. Rayssiguier Y, Guex E, Weiser D. Effect of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet. J Nutr. 1981;111:1876–83.

    PubMed  CAS  Google Scholar 

  91. Luthringer C, Rayssiguier Y, Gueux E, et al. Effect of moderate magnesium deficiency on serum lipids, blood pressure and cardiovascular reactive in normotensive rats. Br J Nut. 1988;59:243–50.

    Article  CAS  Google Scholar 

  92. Beller GA, Hood Jr WB, Abelmann WH, et al. Correlation of serum magnesium levels and cardiac digitalis intoxication. Am J Cardiol. 1974;33:225–9.

    Article  PubMed  CAS  Google Scholar 

  93. Arsenian MA. Magnesium and cardiovascular disease. Prog Cardiovasc Dis. 1993;35:271–310.

    Article  PubMed  CAS  Google Scholar 

  94. Zwillinger L. Uber die Magnesiumwirkung auf das Herz. Klin Wochenschr. 1935;14:1329–433.

    Article  Google Scholar 

  95. Chadda KD, Lichstein E, Gapta P. Hypomagnesemia and refractory cardiac arrhythmia in a nondigitalized patient. Am J Cardiol. 1973;31:98–100.

    Article  PubMed  CAS  Google Scholar 

  96. Tzivoni D, Keren A. Suppression of ventricular arrhythmias by magnesium. Am J Cardiol. 1990;65:1397–9.

    Article  PubMed  CAS  Google Scholar 

  97. Tzivoni D, Keren A, Cohen AM, et al. Magnesium therapy for torsade de pointes. Am J Cardiol. 1984;53:528–30.

    Article  PubMed  CAS  Google Scholar 

  98. Iseri LT, Fairshter RD, Hardemann JL, et al. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J. 1985;110:789–94.

    Article  PubMed  CAS  Google Scholar 

  99. Agus ZS, Morad M. Modulation of cardiac ion channels by magnesium. Annu Rev Physiol. 1991;53:299–307.

    Article  PubMed  CAS  Google Scholar 

  100. Saris NE, Mervaala E, Karppanen H, et al. Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294:1–26.

    Article  PubMed  CAS  Google Scholar 

  101. Verduyn SC, Vos MA, van der Zande J, et al. Role of interventricular dispersion of repolarization in acquired torsade de-pointes arrhythmias: reversal by magnesium. Cardiovasc Res. 1997;34:453–63.

    Article  PubMed  CAS  Google Scholar 

  102. Davidenko JM, Cohen L, Goodrow R, et al. Quinidine induced action potential prolongation, early after depolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium. Circulation. 1989;79:674–86.

    Article  PubMed  CAS  Google Scholar 

  103. Fiset C, Kargacin ME, Kondo CS, et al. Hypomagnesemia: characterization of a model of sudden cardiac death. J Am Coll Cardiol. 1996;27:1771–6.

    Article  PubMed  CAS  Google Scholar 

  104. Ceremuzynski L, Gebalska J, Wolk R, et al. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Intern Med. 2000;247:78–86.

    Article  PubMed  CAS  Google Scholar 

  105. Horner SM. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Circulation. 1992;86:774–9.

    Article  PubMed  CAS  Google Scholar 

  106. Morton BC, Nair RC, Smith FM, McKibbon TG, Poznanski WJ. Magnesium therapy in acute myocardial infarction. Magnesium. 1984;3:346–52.

    PubMed  CAS  Google Scholar 

  107. Rasmussen HS, McNair P, Norregard P, et al. Magnesium infusion in acute myocardial infarction. Lancet. 1986;1:234–6.

    Article  PubMed  CAS  Google Scholar 

  108. Rasmussen HS, Grønbaek M, Cintin C, et al. One-year rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clin Cardiol. 1988;11:377–81.

    Article  PubMed  CAS  Google Scholar 

  109. Smith LF, Heagerty AM, Bing RF, et al. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol. 1986;12:175–80.

    Article  PubMed  Google Scholar 

  110. Abraham AS, Rosenman D, Meshulam Z, et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med. 1987;147:753–5.

    Article  PubMed  CAS  Google Scholar 

  111. Ceremuzynski L, Jurgiel R, Kulakowski P, et al. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate. Am Heart J. 1989;118:1333–4.

    Article  PubMed  CAS  Google Scholar 

  112. Shechter M, Hod H, Marks N, et al. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol. 1990;66:271–4.

    Article  PubMed  CAS  Google Scholar 

  113. Shechter M, Hod H. Magnesium therapy in aged patients with acute myocardial infarction. Magnesium Bull. 1991;13:7–9.

    Google Scholar 

  114. Feldstedt M, Boesgaard S, Bouchelouche P, et al. Magnesium substitution in acute ischaemic heart syndromes. Eur Heart J. 1991;12:1215–8.

    Article  PubMed  CAS  Google Scholar 

  115. Teo KK, Yusuf S, Collins R, et al. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. Br Med J. 1991;303:1499–503.

    Article  CAS  Google Scholar 

  116. Woods KL, Fletcher S, Roffe C, et al. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the Second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339:1553–8.

    Article  PubMed  CAS  Google Scholar 

  117. Woods KL, Fletcher S. Long term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the Second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994;343:816–9.

    Article  PubMed  CAS  Google Scholar 

  118. Shechter M, Hod H, Chouraqui P, et al. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol. 1995;75:321–3.

    Article  PubMed  CAS  Google Scholar 

  119. ISIS-4. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669–85.

    Google Scholar 

  120. Shechter M, Hod H, Rabinowitz B, et al. Long-term outcome in thrombolysis-ineligible acute myocardial infarction patients treated with intravenous magnesium. Cardiology. 2003;99:203–10.

    Article  CAS  Google Scholar 

  121. Magnesium in Coronaries (MAGIC) trial investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the coronaries (MAGIC) trial: a randomized controlled trial. Lancet. 2002;360:1189–96.

    Article  Google Scholar 

  122. Li J, Zhang Q, Zhang M, et al. Intravenous magnesium for acute myocardial infarction. Cochrane Database Syst Rev. 2007; 2. Art. No.: CD002755. doi: 10.1002/14651858.CD002755.pub2

  123. Cohen N, Almoznino-Sarfian D, Zaidenstein R, et al. Serum magnesium aberrations in furosemide treated patients with chronic congestive heart failure: pathophysiological correlates and prognostic evaluation. Heart. 2003;89:411–6.

    Article  PubMed  CAS  Google Scholar 

  124. Fakunding JL, Chow R, Catt KJ. The role of calcium in the stimulation of aldosterone production by adrenocorticotropin, angiotensin II, and potassium in isolated glomerulosa cells. Endocrinology. 1979;105:327–33.

    Article  PubMed  CAS  Google Scholar 

  125. Adamopoulos C, Pitt B, Sui X, et al. Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study. Int J Cardiol. 2009;136:270–7.

    Article  PubMed  Google Scholar 

  126. Stepura OB, Martynow AI. Magnesium orotate in severe congestive heart failure (MACH). Int J Cardiol. 2009;131:293–5.

    Article  PubMed  CAS  Google Scholar 

  127. Seelig MS. Possible roles of magnesium in disorders of the aged. In: Regelson W, Sinex FM, editors. Intervention in the aging process, Part A: quantitation, epidemiology, clinical research. New York: AR Liss, Inc; 1983. p. 279–305.

    Google Scholar 

  128. Johansson G. Magnesium metabolism: studies in health, primary hyperparathyroidism and renal stone disease. Scand J Urol Nephrol. 1979;51:1–47.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Tel Aviv University, Tel Hashomer, 52621, Israel

    Michael Shechter M.D., M.A. (Senior Cardiologist and Director) & Alon Shechter (Tel Hashomer and the Sackler Faculty of Medicine)

  2. Clinical Research Unit, Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, 52621, Israel

    Michael Shechter M.D., M.A. (Senior Cardiologist and Director)

Authors
  1. Michael Shechter M.D., M.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alon Shechter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Shechter M.D., M.A. .

Editor information

Editors and Affiliations

  1. Arizona Health Science Center, Mel and Enid Zuckerman, University of Arizona, 1295 N. Martin, Tucson, 85724-5155, Arizona, USA

    Ronald Ross Watson

  2. Dept. Nutrition & Dietetics, King's College, Stamford St. 150, London, SE1 9NH, United Kingdom

    Victor R. Preedy

  3. Division of Health Promotion Sciences, Mel and Enid Zuckerman, University of Arizona, 1295 N. Martin Avenue, Tucson, 85724, Arizona, USA

    Sherma Zibadi

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Shechter, M., Shechter, A. (2013). The Role of Magnesium in the Cardiovascular System. In: Watson, R., Preedy, V., Zibadi, S. (eds) Magnesium in Human Health and Disease. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-044-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-044-1_13

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-043-4

  • Online ISBN: 978-1-62703-044-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation